(AKCA) – PRNewswire
-
Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product
-
Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics
-
Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics
-
Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020
-
Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020
-
Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress 2020
-
Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020
-
Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany
-
Ionis reports second quarter 2020 financial results and recent business achievements
-
Akcea Reports Financial Results and Highlights for Second Quarter 2020
-
Akcea Announces Approval for Reimbursement of TEGSEDI® (inotersen) in Austria for Treatment of Hereditary Transthyretin Amyloidosis with Polyneuropathy
-
Akcea Therapeutics to Hold Second Quarter 2020 Financial Results Webcast
-
Akcea Appoints New Senior Vice President, Global Medical Affairs
-
Akcea Announces Appointment of New Chief Medical Officer
-
Akcea Appoints Tracy Palmer Berns as Chief Compliance Officer
-
Akcea Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
-
Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy
-
Akcea announces approval for reimbursement of TEGSEDI® (inotersen) in Italy for treatment of hereditary transthyretin amyloidosis with polyneuropathy
-
Akcea announces approval for reimbursement of TEGSEDI® (inotersen) in Portugal for treatment of hereditary transthyretin amyloidosis with polyneuropathy
-
Akcea Announces Appointment of New Chief Financial Officer
-
Akcea Announces Approval for Reimbursement of TEGSEDI® (inotersen) in Spain for Treatment of Hereditary Transthyretin Amyloidosis with Polyneuropathy
-
Akcea Expands Leadership Team with Appointment of Carla Poulson as Senior Vice President and Chief Human Resources Officer
-
Ionis reports first quarter 2020 financial results and recent business achievements
-
Akcea Reports Financial Results and Highlights for First Quarter 2020
-
Ionis provides fourth quarter and full year 2019 financial results
-
Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx
-
Ionis provides third quarter financial results and improved 2019 guidance
-
Ionis Reports Second Quarter 2019 Financial Results
Back to AKCA Stock Lookup